These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32636850)

  • 1. Mesenchymal Stromal Cells, a New Player in Reducing Complications From Liver Transplantation?
    Owen A; Newsome PN
    Front Immunol; 2020; 11():1306. PubMed ID: 32636850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGFRα/Sca-1 Sorted Mesenchymal Stromal Cells Reduce Liver Injury in Murine Models of Hepatic Ischemia-Reperfusion Injury.
    Owen A; Patten D; Vigneswara V; Frampton J; Newsome PN
    Stem Cells; 2022 Nov; 40(11):1056-1070. PubMed ID: 35999023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Improve Liver Regeneration After Ischemia Reperfusion Injury in Mice.
    Anger F; Camara M; Ellinger E; Germer CT; Schlegel N; Otto C; Klein I
    Stem Cells Dev; 2019 Nov; 28(21):1451-1462. PubMed ID: 31495270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.
    Detry O; Vandermeulen M; Delbouille MH; Somja J; Bletard N; Briquet A; Lechanteur C; Giet O; Baudoux E; Hannon M; Baron F; Beguin Y
    J Hepatol; 2017 Jul; 67(1):47-55. PubMed ID: 28284916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury.
    Rowart P; Erpicum P; Detry O; Weekers L; Grégoire C; Lechanteur C; Briquet A; Beguin Y; Krzesinski JM; Jouret F
    J Immunol Res; 2015; 2015():602597. PubMed ID: 26258151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equal distribution of mesenchymal stem cells after hepatic ischemia-reperfusion injury.
    Isbambetov A; Baimakhanov Z; Soyama A; Hidaka M; Sakai Y; Takatsuki M; Kuroki T; Eguchi S
    J Surg Res; 2016 Jun; 203(2):360-7. PubMed ID: 27363644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation.
    Lohan P; Murphy N; Treacy O; Lynch K; Morcos M; Chen B; Ryan AE; Griffin MD; Ritter T
    Front Immunol; 2018; 9():2666. PubMed ID: 30515159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles from bone marrow-derived mesenchymal stem cells protect against murine hepatic ischemia/reperfusion injury.
    Haga H; Yan IK; Borrelli DA; Matsuda A; Parasramka M; Shukla N; Lee DD; Patel T
    Liver Transpl; 2017 Jun; 23(6):791-803. PubMed ID: 28407355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?
    Owen A; Newsome PN
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(10):G791-800. PubMed ID: 26316587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials.
    Pileggi A; Xu X; Tan J; Ricordi C
    Curr Opin Organ Transplant; 2013 Dec; 18(6):672-81. PubMed ID: 24220050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stromal Cells for Transplant Tolerance.
    Podestà MA; Remuzzi G; Casiraghi F
    Front Immunol; 2019; 10():1287. PubMed ID: 31231393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation.
    Hu C; Li L
    J Transl Med; 2019 Dec; 17(1):412. PubMed ID: 31823784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Extracellular Vesicles Derived from Mesenchymal Stem/Stromal Cells on Liver Diseases.
    Zheng W; Yang Y; Sequeira RC; Bishop CE; Atala A; Gu Z; Zhao W
    Curr Stem Cell Res Ther; 2019; 14(5):442-452. PubMed ID: 30854976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.
    Du Z; Wei C; Yan J; Han B; Zhang M; Peng C; Liu Y
    Liver Transpl; 2013 Feb; 19(2):215-25. PubMed ID: 23193024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells for tolerance induction in organ transplantation.
    Casiraghi F; Perico N; Remuzzi G
    Hum Immunol; 2018 May; 79(5):304-313. PubMed ID: 29288697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases.
    Hu C; Wu Z; Li L
    J Cell Mol Med; 2020 Jan; 24(1):40-49. PubMed ID: 31691463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells to promote kidney transplantation tolerance.
    Casiraghi F; Remuzzi G; Perico N
    Curr Opin Organ Transplant; 2014 Feb; 19(1):47-53. PubMed ID: 24257324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death.
    Stone ML; Zhao Y; Robert Smith J; Weiss ML; Kron IL; Laubach VE; Sharma AK
    Respir Res; 2017 Dec; 18(1):212. PubMed ID: 29268735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stromal Cell Therapy in Novel Porcine Model of Diffuse Liver Damage Induced by Repeated Biliary Obstruction.
    Vištejnová L; Liška V; Kumar A; Křečková J; Vyčítal O; Brůha J; Beneš J; Kolinko Y; Blassová T; Tonar Z; Brychtová M; Karlíková M; Racek J; Mírka H; Hošek P; Lysák D; Králíčková M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease.
    Driscoll J; Patel T
    J Gastroenterol; 2019 Sep; 54(9):763-773. PubMed ID: 31270691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.